Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 7.872% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
(a) CCCN(CCC)C(=O)c1cc(S(=O)(=O)N2CCCCC2)c[nH]1
(b) CC1(C)SC[C@H](C(=O)Nc2cccc(Cl)c2)N1C=O
Answer: b. CC1(C)SC[C@H](C(=O)Nc2cccc(Cl)c2)N1C=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1(C)SC[C@H](C(=O)Nc2cccc(Cl)c2)N1C=O
CC1(C)SC[C@H](C(=O)Nc2cccc(Cl)c2)N1C=O
(4S)-N-(3-chlorophenyl)-3-formyl-2,2-dimethyl-1,3-thiazolidine-4-carboxamide